Vol. 175, No. 3, 1991
BIOCHEMICAL
March 29, 1991
FUSOGENIC
AND BIOPHYSICAL RESEARCH COMMUNICATIONS Pages 8724379
ACTIVITY OF SIV (SIMIAN IMMUNODEFICIENCY VIRUS) LOCATED IN THE GP32 NH2 TERMINAL DOMAIN
I. Martin, F. Defrise-Quertain, T. Saermark,* A. Burny,il R. Brasseur,
Laboratoire
“Laboratoire
Received
V. Mandieau, N. M. Nielsen,* J-M. Ruysschaert, and M. Vandenbranden
de Chimie-Physique des Macromol&cules aux Interfaces Universite Libre de Bruxelles, 1050 Bruxelles, Belgium
*EEC concerted
action/
Medical physiology 2200 Kobenhavn
de Chimie
January
Biologique,
14,
PEPTIDES
B, Panum Institute, N, DENMARK
CP206/2,
Blegdamsvej
Universite Libre de Bruxelles, Genbse, Belgium
3C, DK-
1640 Rhode-St-
1991
Peptides of 12, 16 and 24 amino acids length corresponding to the NH2 terminal sequence of SIV gp32 were synthesized. Fluorescence energy transfer studies have shown that those peptides can induce lipid mixing of SUV (Small Unilamellar Vesicles) of various compositions at pH 7.4 and 37°C. LUV (Large Unilamellar Vesicles) were shown to undergo fusion, provided they contained PE in their lipid composition. This work is an attempt to determine how the fusogenic activity depends on the structure of the peptide inserted into a lipidic environment. The peptides secondary structure and orientation in the lipid bilayer were determined using Fourier Transform infrared spectroscopy (FTIR). They adopt mainly a &sheet conformation in the absence of lipids. After interaction with DOPC SUV, the l&sheet is partly converted into a-helix oriented obliquely with respect to the membrane interface. We bring here evidence that this oblique orientation is a prerequisite to the fusion process. 0 1991 Academic Press. Inc.
Membrane molecular with
fusion
mechanism
model
of membrane
membranes
destabilization fusion,
is one of the primary has
of the lipid
were
described
domain” peptides
However,
there is no obvious
Our strategy
understood.
demonstrated
bilayer.
poorly
that
Non bilayer
of the hemagglutinin corresponding
membrane
structures,
to this
domain between
events which
to a better understanding
is based on the use of synthetic
(1). However,
fusion
peptides
In influenza into
induce
fusion
occur prior
work
requires
the
for membrane
or proteins
could
virus, the so-called
the lipid
the conformational
the
Extensive
responsible
by which
is able to insert
relationship
and the destabilizing
attempt to contribute
remains
and induce fusion is unknown.
synthetic
fusion domain
infection
(2) but the mechanism
generate such structures “fusion
fusion
event of virus
of
bilayer
(3) and
liposomes properties
(4). of the
to fusion. This work
is an
of such a relationship. peptides
corresponding
to the fusogenic
sequence of the SIV gp32. We report here that the capacity of such synthetic depends on the lipid
composition
0006-291X/91 $1.50 Copyright 0 1991 by Academic Press, Inc. All rights of reproduction in any form reserved.
peptides
of vesicles, the structure
872
to induce
fusion of liposomes
and the mode of insertion
of
Vol.
175,
No.
BIOCHEMICAL
3, 1991
the peptides
into lipid
the mean orientation Peptides lipid
with
fusogenic
membrane.
MATERIAL
model membranes. of o-helix activity
AND
BIOPHYSICAL
Polarized
and B-sheet
infrared
in the lipid
were demonstrated
The role of this unusual orientation
RESEARCH
COMMUNICATIONS
spectroscopy bilayer
to be obliquely
spectra allows
to be determined. oriented
into the
in the fusion process is discussed.
AND METHODS
Material: Bovine brain phosphatidylethanolamine (PE), egg phosphatidylcholine (PC), soya bean phosphatidylinositol (PI) and cholesterol (Chol) were purchased from SIGMA Chemical Company (Saint Louis, USA). 1,3-diazol) Dioleoylphosphatidylcholine N-(Nitrobenzo-2-oxa (DOW, phosphatidylethanolamine (NBD-PE) and N-(lissamine rhodamine B sulfonyl) phosphatidylethanolamine (Rh-PE) were from Avanti Polar Lipid Inc. (Birmingham, Ala, USA). Peptide synthesis: Peptides (F1G.I) were synthesized using a commercially available peptide synthesizer (model Biolynx, Pharmacia Biochrome, Cambridge UK) and the preweighted Fmoc amino acid OPFP esters supplied for this machine (Pharmacia Biochrome, Cambridge UK). The acylation rate was monitored by the Bioplus software using the release of anionic dye (Acid violet 17.3 mg pr lOOm1 dimethylformamide and 0.14 ml diisopropylethylamine) at 600nm. The principle is known as counter ion distribution monitoring, CDM, and is described in (17). The linkers used resulted in release of peptide amide (Ultrosyn C, Pharmacia Biochrome, Cambridge UK). The peptides were cleaved from the resin using trifluoroacetic acid with the addition of 2% anisol and 2% ethanedithiol for 2h followed by ether precipitation. The peptide was purified to more than 95% purity by HPLC on a TSK l20T reverse phase column (7.5 x 300mm) (Pharmacia, Sweden).The peptides typically eluded at 65% acetonitrile (between 65 and 75%) using a linear gradient over 90 minutes from 0 to 80% acetonitrile in 0.1% trifluoroacetic acid. The sequence was verified by protein sequencing on an Applied iosystem sequencer. The peptides were dissolved in DMSO at concentration of 8 loVesicles preparation: -Multilamellar vesicles (MLV) were obtained by vortexing a lipid film in a buffer (10 mM Hepes, 150 mM NaCl, pH 7.4). -Small unilamellar vesicles (SUV) were prepared by sonication of the MLV with a Branson Sonifier B12 for 15 min. The sonicated suspension was centrifuged at 8000xg for 10 min to remove titanium and residual multilamellar vesicles. -Large unilamellar vesicles (LUV) were prepared according to the extrusion procedure (5) using an Extruder (Lipex Biomembranes Inc., Vancouver, Canada). Briefly, freezed and thawed MLV were extruded 10 times through two stacked polycarbonate membranes with a pore size of 0.1 m (Nuclepore Corp., Pleasanton, CA, IJSA.). Liposome fusion assay: Lipid mixing was determined by changes in fluorescence intensity resulting from fluorescence energy transfer between the probes NBD-PE and Rh-PE, as described (6). Fluorescence was monitored using a Jobin Yvon JY3D spectrofluorimeter with excitation and emission slits of 4nm. Both probes were introduced into the lipid film and SUV or LUV were prepared as described above. Labeled liposomes containing both probes at 0.6% (molar ratio) each, were mi ed in a l/9 mole ratio with probe free liposomes at a final lipid concentration of 3 lo- %M. The initial fluorescence of the l/9 (labeled/unlabeled) suspension was taken as 0% fluorescence and the 100% fluorescence was determined using an equivalent concentration of vesicles prepared with 0.06% of each fluorescent phospholipid. The suspensions were irradiated at 470nm and the NBD fluorescence was recorded at 530nm. Infrared attenuated total reflection spectroscopy (ATR): Spectra were recorded with a Perkin Elmer infrared spectrophotometer FTIR 1720X equipped with a Perkin Elmer microspecular reflectance accessory (ref P.E 221-0357) and a polarizer mount assembly 873
Vol.
175,
No.
3, 7991
BIOCHEMICAL
AND
BIOPHYSICAL
RESEARCH
COMMUNICATIONS
with a silver bromide element (ref P.E.L 106-0249). The internal reflection element was a Germanium plate (50X20X2mm) with an aperture angle of 45”, yielding 25 internal reflections. A complete description of the procedures allowing the determination of the peptide secondary structure and of its orientation is given in (7) and (8). Mu_[4iluyers formation: SIV peptides, dissolved in DMSO, were added to DOPC SUV (13 10 M)in buffer at a molar lipid/peptide ratio of 65/l. After an incubation of 1 hour at 37”c, aggregated and/ or fused liposomes were centrifuged (Sigma 1OlM centrifuge) at 10 000 X g for 15 min at room temperature. A flotation sucrose gradient (30%-2%) was used to separe the lipid-peptide complex from the free peptides or the free liposomes. After centrifugation (Ultracentrifuge Beckman L765) at 35 OOOXg at 4°C for 16 hours in a SW60 Beckman rotor, the gradient was fractionated and the fractions were tested for the presence of PC using the calorimetric test of Boehringer Mannhein. Liposomes were collected and dialyzed 36 hours at 4°C against tridistilled water (microdialyzer, Pierce) to eliminate sucrose and salts which interfere with the IR analysis. Oriented multilayers were obtained by slow evaporation of the liposomes under N2 on one side of the germanium plate. To differentiate between the a-helix and the random structures, the multilayers were exposed 3 hours to D20 - saturated N2 (7). RESULTS Lipid
mixing
assays.
Fluorescence (Fig.1) rapid
energy
studies show that addition
to SUV of DOPC or PC/PE/SM/Chol lipid
mixing
compositions The
transfer
presence
of
(DOPC/Chol) maximum
lipid
which
Surprisingly,
labeled
the fusion mixing
and unlabeled
in
DOPC
whose curvature
with
neutral
SUV
the peptide
and stability
fusion
better
activity
mimick
when
DOPC liposomes
PE is replaced
with
PC
the lipid
and
l/.75
(data not shown).
The
PC/PE/SM/Chol,
mammalian
a
plasma cell.
length increases.
membrane
vesicles (LUV),
structure.
Fusion
liposomes (fig 3). No lipid mixing
in the lipid
formed
during
:52.6, 26.3, 21% w/w) bilayer
forms hexagonal
the fusion mechanism
*SIVITlZaa:GLY-VAL-PHE-VAL-LEU-GLY-PHE-LEU-GLY-PHE-LEU-ALA 1 5 *sIVsFIlCaa:GLY-VAL-PHE-VAL-LEU-GLY-PHE-LEU-GLY-PHE-LEU-ALA 1 5 -THR-ALA-GLY-SER 15 16 *sI~ZI;aa:GLY-VAL-PHE-VAL-LEU-GLY-PHE-LEU-GLY-PHE-LEU-ALA 1 5 -THR-ALA-GLY-SER-ALA-MET-GLY-ALA-ALA-SER-LEU-THR 15 20
FIGURE (BK28).
l/.5
at was
or on
(data not shown).
process at 37°C and pH 7.4. PE
structures
ratio
on large unilamellar
(PC /SM/Chol
The presence of phosphatidylethanolamine the fusion
a
For all the liposome
of
made
lipids of a typical
37°C was only observed with the PC/PE/SM/Chol
lipidic
a molar
the extent of fusion decreases when the peptide
We also determined
observed
in
of the SIV peptides
is observed
contains the major
vesicles (Fig.2).
induces
at 37°C than at 20°C (data not shown).
vesicle
activity
type SIV peptides
(26.3, 26.3, 26.3, 21 % w/w)
is more efficient
cholesterol
reduces of
composition
between
tested, the fusion
of the wild
seems to be necessary for phases which
10
12
10
10
24
1. Amino acid sequences of peptides from the gp32 N-terminus
874
are transient
(9)
of SIV,,,
Vol.
175,
No.
3, 1991
BIOCHEMICAL
AND
% Fusion
RESEARCH
COMMUNICATIONS
% Fusion
70
a suv
BIOPHYSICAL
70SUV
DOPC
PC/PE/SM/Chol
60,
50 i 40
i
30.
SlVWTlDaa
I
WTlGas
20 WT24aa 10
0
2
4
6
8
(mi$
10
0
2
4
6
6
10
Time
12
Time
FIGURE 2. Fusion percentage of small SIVWT12aa, SIVWTl63 and SIVWT24aa
unilamellar vesicles (SUV) after addition of peptides at pH = 7.4 and 7°C. The lipid 3 peptide concentration is 1.3 IO- M. The molar
concentration is 3 IO M and the lipid/peptide ratio is 25. (a)Fusion of DGPC liposomes in the presence of SIVWT peptides. (b)Fusion of PC/PE/SM/Chol (26.3, 26.3, 26.3, 21 % w/w) liposomes
in the presence
of
SIVWT peptides.
Structure
and
In order
to investigate
spectroscopy
orientation
methods unordered
cm-‘)
bonding with
components
the structure
(10). Vibrational
band (1600-1700 hydrogen
of the fusogenic
a band
structures
are sensitive fitting
(7),(8).
bilayer.
in a lipid
or peptide,
procedure
The combination allows
secondary
Moreover,
we used infrared
enhancement
Total
O-sheet
Reflection
I
SlWTlPaa
SIVWTlGaa
0
5
10
15
20
25
FIGURE 3. Fusion percentage of large unilamellar vesicles (LUV) of PC/PE/SM/Chol (26.3,26.3,26.3,21 % w/w) $fter addition of SIVWT peptides at 37-C a-y pH 7.4. The lipid concentration is 3 lo- M and the peptide concentration is 1.3 10 M. The molar lipid/peptide ratio is 25.
875
and
infrared
% Fusion ,Ol
1
assessment of various
such as a-helix,
the use of Attenuated
the Amide
as this involves specific
of resolution
the quantitative structure
bilayer
and particularly
to the secondary structure
groups.
or peptide
in the lipid
of the peptide
bands of protein
of the C=O
of protein
peptides
(mid
Vol.
175, No. 3, 1991
BIOCHEMICAL
AND BIOPHYSICAL
RESEARCH COMMUNICATIONS
TABLE 1. Proportion of the different secondary structures of SIVWTl2aa, SIVWT16aa and SIVWT24aa in the absence and in the presence of lipid (SUV of DOPC). The molar livid/vevtide ratio is 65 a-helix
SAMPLE
0 48
67 34
33 19
SIVWT.16aa + DOPC
9 39
76 58
15 3
SIVWT24aa + DOPC
9 45
53 20
38 35
allows
spectra to be recorded
gained about the orientation orientation
of different
of the a-helix
the peptide Polarization
on ordered
structures
and D-sheet structures
bond corresponding
and perpendicular
between
%
SIVWT12aa + DOPC
spectroscopy
(0”)
random %
P-sheet
%
of protein
incident
as the dichroic
the C=O band and a normal
and information
or peptide
was determined
to the C=O group. Spectra
(90”) polarized
was expressed
bilayers
light
ratio
from the orientation with
plate surface
The
of
parallel
respect to the ATR
Rat,. = A9p/AOo.
to the ATR
(1 I). The mean
were recorded
with
to be
plate.
mean angle
is calculated
from Rat,
(7). IR spectra of SIVWT solution
in
DMSO
conformation The
on the ATR
of DOPC
1650 cm-l
significant
SUV
to the lipid/peptide
ratio Ratr=
A9O/AO
is neither
intermediate D-sheet
revealed
evaporation
of a concentrated
that the peptides
the appearance
structure (table
orientation
of a new
(40 to 50%) content 1). The
adopt
a g-sheet
percentage
large
peak centered
structure
(Fig 4). This
is accompanied
of a-helix
by a
structure
is
ratio (table 2).
with
the incident
=1.04 corresponding
parallel
structure
orientations
by direct
of the presence of an a-helix
structure
From the spectra recorded helix
induces
of the a-helix
of the B-sheet
proportional
plate
characteristic
increase
decrease
alone obtained
(table 1).
presence
around
peptides
nor
light polarized
to the helical
perpendicular
in the lipid
corresponds
to the lipid
bilayer.
The dichroic
to an orientation
did not change whatever
acyl
indicates chain
ratio Ratr=2.3
parallel
the lipid/peptide
at 90” and O”, the dichroic
structure
to the lipid
but
that the Qadopts
an
associated to the bilayer.
These
ratio.
DISCUSSION Our results show that synthetic N-terminal promote
fusion
properties similar peptides
domain
of lipid
attributed
observation (12), giving
peptides
of 12, 16 and 24 residues corresponding
of the transmembrane vesicles,
glycoprotein
demonstrating
further
influenza
experimental
of SIV,
to the
are able to
that at least a part of the fusogenic
tv gp32 depends on a limited was made with
(gp32)
stretch of its N-terminal
peptides
support
sequence in viral fusion.
876
(4) and more recently
for the role of N-terminal
domain. with
A HIV
fusogenic
Vol.
BIOCHEMICAL
175, No. 3, 1991
p-turn
P-sheet
AND BIOPHYSICAL
random
a-helix
RESEARCH COMMUNICATIONS
p-sheet
a
1700
1680
1640
1660
1620
1600
b _--. ,,,’ -.\:,\
.‘L_ ,.,.--.._ ,>’ :\ // ,:’J’ ‘/ ,I
,.../~ ,I ..:. 2,’ (,'. ,' ,,..._
9
',.,.. -. ...'
./ <...z-.-.,~::r..-~~~~~-.z+--
--... *;&..L;~ ~~~h~&+s"-‘.
/ _--....
._-
-..-- ._...,_ ~~;IIzz--";w
---
i
.___._
,.,“.., \\ i' /
. . .. . . .;--=--=a:
-----_
\, !
1, '\
‘>' '~ ,/ ,,,, ,..,, j,' j>,.' .i .: . . .. ,/' :. ...
, '<
___-
',
:
k,
,.
,.... .\ ;c-... .---..ycL -~:~-~~~,.~~
y--w----~--~-=2-~=m+a
rm-~rrrr7-rr-rp-rrrTi~l-~r~~r~r~l 1660
>\,, \
,:. Ii
-I ..:.I--__ -...- :::Li--:y..~m~u
---.-c----z---
,.-.
1660
1640
, , , , , -1 Icm
1620
1600
FIGURE 4. Curve fitting of the amide I’ region of the SIVWT12aa at pH 7.4 in the absence of lipid (a) and in the presence of SUV DOPC (b). The result of the fitting appears under the curve. The vertical dotted lines define the region of the spectrum assigned to the different secondary structures. The sum of the components is represented by the dotted spectrum.
In contrast shorter
to studies on influenza,
one,
fusogenic,
we show
here
the 12 amino
that
where
longer
12 residues
and
model
residues peptide
has been proposed of SUV towards
of their surrounding
TABLE
peptides
than
are highly
This result suggests that in the
“fusion
the higher
domain” fusogenic
could be shorter. capacity
A
of the 12
(13).
The susceptibility curvature
to explain
were more fusogenic
16 residues
acids being the most efficient.
case of SIV (and perhaps other viruses) the so-called theoretical
peptides
lipid
fusion
or destabilization
bilayer.
is attributed
Here, we show that when
to the strong the appropriate
2. Proportion of the different secondary structures of SIVWT12aa presence of lipid (SUV of DOPC) for different lipid/peptide ratios
SIWT12aa lipid/peptide 18 36 65
+ DOPC ratio
a-helix % 17 35 48
877
P-sheet % 83 47 34
random % 0 18 19
in the
Vol.
175, No. 3, 1991
lipid composition of LUV
is chosen, LUV
is probably
unsaturated
in
destabilization
bilayer
several
component
infrared
membrane
fusion
conformational
transition
similar
to a-helical
data
processes
property
(9).
to undergo
which
The
a
is thought
need
for
to
intrinsic
fusion. that
from R-sheet to a-helix
seems not to be a specific
is known
PE with
in vesicle fusion suggests a possible role
indicate
transition
Indeed,
HII phase, a structure
factors in viral membrane
spectroscopy
S-sheet
fusion too. The decreased stability
of cell membranes,
to hexagonal
factors (PE or surface curvature)
for those additional Our
RESEARCH COMMUNICATIONS
due to the presence of phosphatidylethanolamine.
from
a role
AND BIOPHYSICAL
are able to undergo
acyl chains, a natural
phase transition play
BIOCHEMICAL
fusogenic
peptides
when interaction
was demonstrated of the fusion
undergo
a
with lipids occurs. A
with influenza
peptides (14) but
domain since it has also been observed
in signal sequence peptides (15) and some model peptides (16). As observed
in the spectra, even at high
separated spectral components the conversion
to a-helix
should reflect lipid
bilayer
lipid-peptide
in the a-helix is uncomplete.
sheet. Indeed,
it
conformations,
could
structure,
is hard
The
occurence
coexist
reason why the peptide
within
should
that
two
well
enlarge
well that
components
one penetrating
into the
in the aqueous phase as a B-
defined
a-helix
the same short sequence
gradually
showing
of two spectral
populations,
the other, remaining
to believe
there are two major
and B-sheet spectral domains,
the presence of two separate peptide in an a-helical
ratio,
its a-helix
and
D-sheet
and we see no obvious
domain
while
lipid/peptide
ratio is increasing. When fused vesicles were not separated infrared
spectrosopy,
idea that peptides
spectra reveal a major
having not interacted
In the SIV peptide, the C-terminus. domain
from
g-sheet
spectral component,
to our previous an unusual
modelling
orientation
has been demonstrated
peptide
to the lipid bilayer
was calculated
However,
to conclude
orientation
of a peptide
spectroscopy orientation.
populations
The prediction
small differences that the fusogenic orientation.
in the lipid
is unable to discriminate
(or more)
that fusogenic it should
a fixed uniaxial
capacity orientation giving
878
orientations
its orientation
several peptides
as the gp32 NH2-terminal
having
domain
induce
A tilt angle
depends
on the
that infrared and a mixture
an average
gives only a static view of the phenomenon changing
not
in this work.
be kept in mind
orientations
for various
to
for SIV. This is in accordance
bilayer,
energies
synthesized
interface.
spectroscopy
between different
segment is actually
We recently
same hydrophobicity
with
approach
in calculated
the
According
of residues might
at the lipid-water
found by infrared
it is generally
helices of proteins.
distribution
with the mean angle of orientation even if it is tempting
supporting
to be associated to the fusion
segments and surface-seeking studies, this asymmetric
of the fusogenic
of 52” from the normal
prior
increases along the helix from the N-terminus
of a series of viruses (13) and to signal peptides (11) whereas
observed in transmembrane
of two
on a sucrose gradient
with vesicles form a separate B-sheet population.
the hydrophobicity
This distribution
free peptides
oblique and the
could
reflect
the fact
quickly
around
a mean
the same length
and the
but for which
the calculated
Vol.
BIOCHEMICAL
175, No. 3, 1991
orientation between fusion peptides
into the lipid the oblique
orientation
(to be published).
Another
in the SIV glycoprotein
expressed in mammalian syncytia
bilayer
formation
has been modified. of the peptides way to verify precursor
RESEARCH COMMUNICATIONS
A good correlation
and their capacity this correlation
using directed
This
work
is currently
was observed
to induce
liposomes
is to integrate
mutagenesis.
cells and the capacity of such modified
is measured.
results seem encouraging
AND BIOPHYSICAL
The precursor
glycoproteins
in progress
these is
to induce
and preliminary
( Burny A., personal communication.)
ACKNOWLEDGMENTS This work was performed with the financial support of BNB (Banque National de Belgique), FNRS (Fonds National de la Recherche Scientifique ), IRSIA (Institut pour 1’Encouragement de la Recherche Scientifique dans 1’Industrie et I’Agriculture) and Smith Kline Beecham. One of us (R.B.) is a Research Associate of the National Fund for Scientific Research. We gratefully thank NIH (NIAID grant Al-27136-01Al) and the Commission of the European Communities (SC 1000195) for a continued financial support.
REFERENCES 1. 2. 3. 4. 5. 6. 7. 8. 9. IO. 11. 12. 13. 14. 15. 16. 17.
White J., Kielian M., and Helenius A. (1983) Quart. Rev. Biophys. 16, 151-195. Verkleij A.J. (1984) Biochim. Biophys Acta 779, 43-63. Harter C., James P., Biichi T., and Brunner J., (1989) J. Biol. Chem. 264, 6459-6464. Wharton S.A., Martin S.R., Ruyrok R.W.H., Skehel J.J.,and Wiley D.C. (1988) J. Gen. Virol. 69, 1847-1857. Hope M.J., Bally M.B., Webb G., and Cullis P.R. (1985) Biochim. Biophys. Acta 812, 55-65. Struck D. K., Hoekstra D., and Pagan0 R.. (1981) Biochemistry 20, 4093-4098. Cabiaux V., Brasseur R., Wattiez R., Falmagne P., Ruysschaert J.-M., and Goormaghtigh E. (1989) J. Biol. Chem 264, 4928-4938. Goormaghtigh E., Cabiaux V., and Ruysschaert J.-M. (1990) Eur. J. Biochem. 193, 409-420. Ellens H., Siegel D., Alford D., Yeagle P. Boni L., Lis L., Quinn P., Bentz J. (1989) Biochemistry 28, 3692-3703. Fringeli U. R., Giinthard M. H. in “Membrane Spectroscopy.“, ed. E. Grell Springer-Vellay pp 270-332, (1981). Goormaghtigh E., Martin I., Vandenbranden M., Brasseur R., Ruysschaert J.-M. (1989) Biochem. Biophys. Res. Comm. 158, 610-616. Rafalski M., Lear D., and DeGrado W.F. (1990) Biochemistry 29, 7917-7922. Brasseur R., Vandenbranden M., Cornet B., Burny A., and Ruysschaert J. -M. (1990) Biochim. Biophys. Acta, 1029267-273. Lear J.D., and DeGrado W.F. (1987) J. Biol. Chem. 262, 6500-6505. Roise D., Horvath S.J., Tomich J.M., Richards J.M., Schatz G. (1986) EMBO J. 6,1327-1332. Subbarao N., Parente R., Szoka F., Nadoudi L., Pongracz K. (1987) Biochemistry 26, 2964-2972. Salisbury S.A., Treemeer E.J., Davies J.W., Owen D. (1990) J. Chem. Sot. Chem. Commun. 538-540.
879